PubPeer
The online Journal club
login
create account
Home
Publications
Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma
Molecular Cancer Research (2015) -
Comment
pubmed: 25421750 doi: 10.1158/1541-7786.mcr-14-0157 issn: 1541-7786 issn: 1557-3125
M. Ceccon, L. Mologni, G. Giudici, R. Piazza, A. Pirola, D. Fontana, C. Gambacorti-Passerini
Go to article
Go to preprint
American Association for Cancer Research (AACR)
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})